Biomaterial Database

Coagulation and fibrinogenolysis during whole-body hyperthermia. 1988

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, FRG.

UI	MeSH Term	Description	Entries
D006979	Hyperthermia, Induced	Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.	Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D009369	Neoplasms	New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001777	Blood Coagulation	The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.	Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005338	Fibrin Fibrinogen Degradation Products	Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.	Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005340	Fibrinogen	Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.	Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005353	Fibronectins	Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins.	Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990	Antithrombin III	A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.	Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Activation of coagulation during therapeutic whole body hyperthermia.

August 1986, Thrombosis research,

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Cardiovascular and oxygenation changes during whole body hyperthermia.

January 1982, Advances in experimental medicine and biology,

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Whole-body hyperthermia.

November 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Cerebral autoregulation during whole-body hypothermia and hyperthermia stimulus.

January 1999, American journal of physical medicine & rehabilitation,

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Monitoring arterial blood pressure during whole body hyperthermia.

May 2002, Acta anaesthesiologica Scandinavica,

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Electroencephalographic changes during whole body hyperthermia in humans.

December 1980, Electroencephalography and clinical neurophysiology,

W Klaubert, and K Eisler, and J Lange, and W Wilmanns

Serum thyroid hormone changes during whole body hyperthermia.

December 1984, Cancer,